Bioclinica reports availability of comprehensive COVID-19 clinical endpoint adjudication solution.

Global Banking News-May 8, 2020-Bioclinica reports availability of comprehensive COVID-19 clinical endpoint adjudication solution

(C)2020 ENPublishing - http://www.enpublishing.co.uk

Life science company Bioclinica revealed on Thursday the launch of a specialized out-of-the-box clinical endpoint committee solution programme for the adjudication of adverse events that could result from COVID-19 infection in partnership with Boston Clinical Research Institute, Harvard Medical School as well as adjudicators from cardiology, pulmonology, neurology, hepatology and gastroenterology.

The company added that the clinical adjudication solution's cutting-edge endpoint adjudication platform will help medical researchers discern COVID-related adverse events from those not associated with the virus. The solution is designed to...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT